Clinical Trial Update: Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV [Phase 2]

View source ↗

Summary

Phase 2 immunogenicity study comparing Vacc-4x to placebo in HIV-1 infected patients; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Vacc-4x

Snippet

Sponsor: Bionor Immuno AS | Conditions: HIV I Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-01-05